Use of Tyrosine Kinase Inhibitors (TKIs)

Project Title Use of Tyrosine Kinase Inhibitors (TKIs)
Date Posted
Wednesday, February 28, 2018
Project ID
cder_mpl1r_wp019_nsdp_v01, cder_mpl1r_wp036_nsdp_v01, cder_mpl1r_wp037_nsdp_v01
Status
Complete
Deliverables
Sentinel Modular Program Report: Tyrosine Kinase Inhibitors Report 1
Sentinel Modular Program Report: Tyrosine Kinase Inhibitors Report 2
Sentinel Modular Program Report: Tyrosine Kinase Inhibitors Report 3
Description

These reports contain baseline characteristics of patients receiving four types of tyrosine kinase inhibitors (TKIs) in the Sentinel Distributed Database (SDD). This request was distributed to 16 Data Partners on August 23, 2016; this report contains data from 16 Data Partners.

Medical Product
axitinib
pazopanib
sorafenib
sunitinib
tyrosine kinase inhibitor
Population / Cohort
Individuals 18 years of age or older
Time Period
January 1, 2006 - September 30, 2015
Assessment Type
Exploratory Analyses
Study Type
Modular Program
Data Sources
Sentinel Distributed Database (SDD)
FDA Center
CDER
Scroll to Top